Selective increase of dATP pools upon activation of deoxycytidine kinase in lymphocytes: Implications in apoptosis

Nucleosides, Nucleotides and Nucleic Acids

Volumn 23, Issue 8-9, 2004, Pages 1335-1342

  Keszler, Gergely ^a   Spasokoukotskaja, Tatjana ^a   Csapo, Zsolt ^a   Virga, Szula ^a   Staub, Maria ^a   Sasvari Szekely, Maria ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Apoptosis; Deoxycytidine kinase; DNTP pools; p53; Pifithrin

Indexed keywords

APHIDICOLIN; CLADRIBINE; CYTOCHROME C; DEOXYADENOSINE TRIPHOSPHATE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE KINASE; DNA; ETOPOSIDE; NUCLEOSIDE DERIVATIVE; PIFITHRIN ALPHA; PROTEIN INHIBITOR; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DAMAGE; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; DNA REPAIR; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MITOCHONDRION; PROTEIN DETERMINATION; TONSIL;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOTHIAZOLES; CELLS, CULTURED; CLADRIBINE; CYTOCHROMES C; DEOXYCYTIDINE KINASE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; LYMPHOCYTES; MODELS, BIOLOGICAL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); THIAZOLES; TOLUENE; TONSIL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 10344265013     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-200027586     Document Type: Conference Paper

References (23)

1. Eriksson, S.; Munch-Petersen, B.; Johansson, K.; Eklund, H. Structure and function of cellular deoxyribonucleoside kinases. Cell. Mol. Life Sci. 2002, 59, 1327-1346.
2. Kroep, J.R.; Loves, W.J.; van der Will, C.L.; Alvarez, E.; Talianidis, I.; Boven, E.; Braakhuis, B.J.; van Groeningen, C.J.; Pinedo, H.M.; Peters, G.J. Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity. Mol. Cancer. Ther. 2002, 1, 371-376.
3. Veuger, M.J.; Honders, M.W.; Willemze, R.; Barge, R.M. Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia. Eur. J. Haematol. 2002, 69, 171-178.
4. Mansson, E.; Flordal, E.; Liliemark, J.; Spasokoukotskaja, T.; Elford, H.; Lagerkrantz, S.; Eriksson, S.; Albertioni, F. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance. Biochem. Pharmacol. 2003, 65, 237-247.
5. Chandra, J.; Mansson, E.; Gogvadze, V.; Kaufmann, S.H.; Albertioni, F.; Orrenius, S. Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release. Blood 2002, 99, 655-663.
6. Sasvari-Szekely, M.; Spasokoukotskaja, T.; Szoke, M.; Csapo, Z.; Turi, A.; Szanto, I.; Eriksson, S.; Staub, M. Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2′-deoxyadenosine (Cladribine) in human lymphocytes. Biochem. Pharmacol. 1998, 56, 1175 1179.
7. Csapo, Z.; Sasvari-Szekely, M.; Spasokoukotskaja, T.; Talianidis, I.; Eriksson, S.; Staub, M. Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes. Biochem. Pharmacol. 2001, 61, 191-197.
8. Csapo, Z.; Keszler, G.; Safrany, G.; Spasokoukotskaja, T.; Talianidis, I.; Staub, M.; Sasvari-Szekely, M. Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes. Biochem. Pharmacol. 2003, 65, 2031-2039.
9. Ooi, K.; Ohkubo, T.; Higashigawa, M.; Kawasaki, H.; Sakurai, M. Increased deoxycytidine kinase activity by etoposide in L1210 murine leukemic cells. Biol. Pharm. Bull. 1996, 19, 1382-1383.
10. Van Den Neste, E.; Smal, C.; Cardoen, S.; Delacauw, A.; Frankard, J.; Ferrant, A.; Van den Berghe, G.; Bontemps, F. Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes. Biochem. Pharmacol. 2003, 65, 573-580.
11. Kreder, N.C.; van Bree, C.; Peters, G.J.; Loves, W.J.; Haveman, J. Enhanced levels of deoxycytidine kinase and thymidine kinase 1 and 2 after pulsed low dose rate irradiation as an adaptive response to radiation. Oncol. Rep. 2002, 9, 141-144.
12. Huang, P.; Plunkett, W. Induction of apoptosis by gemcitabine. Oncology 1995, 22, 19-25.
13. Lassota, P.; Kazimierczuk, Z.; Darzynkiewicz, Z. Apoptotic death of lymphocytes upon treatment with 2-chloro-2′-deoxyadenosine (2-CdA). Arch. Immunol. Ther. Exp. 1994, 42, 17-23.
14. Robertson, L.E.; Chubb, S.; Meyn, R.E.; Story, M.; Ford, R.; Hittelman, W.N.; Plunkett, W. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-beta-D-arabinosyl-2- fluoroadenine. Blood 1993, 81, 143-150.
15. Genini, D.; Adachi, S.; Chao, Q.; Rose, D.W.; Carrera, C.J.; Cottam, H.B.; Carson, D.A.; Leoni, L.M. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria. Blood 2000, 96, 3537-3543.
16. Jullig, M.; Eriksson, S. Apoptosis induces efflux of the mitochondrial matrix enzyme deoxyguanosine kinase. J. Biol. Chem. 2001, 276, 24000-24004.
17. Genini, D.; Budihardjo, I.; Plunkett, W.; Wang, X.; Carrera, C.J.; Cottam, H.B.; Carson, D.A.; Leoni, L.M. Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway. J. Biol. Chem. 2000, 275, 29-34.
18. Sherman, P.A.; Fyfe, J.A. Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Anal. Biochem. 1989, 180, 222-226.
19. Oren, M. Decision making by p53: life, death and cancer. Cell Death Differ. 2003, 70, 431-442.
20. Borner, M.M.; Joncourt, F.; Hotz, M.A. Similarity of apoptosis induction by 2-chlorodeoxyadenosine and cisplatin in human mononuclear blood cells. Br. J. Cancer 1997, 76, 1448-1454.
21. Komarov, P.G.; Komarova, E.A.; Kondratov, R.V.; Christov-Tselkov, K.; Coon, J.S.; Chernov, M.V.; Gudkov, A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999, 285, 1733-1737.
22. Hatzis, P.; Al-Madhoon, A.S.; Jullig, M.; Petrakis, T.G.; Eriksson, S.; Talianidis, I. The intracellular localization of deoxycytidine kinase. J. Biol. Chem. 1998, 273, 30239-30243.
23. Johansson, M.; Brismar, S.; Karlsson, A. Human deoxycytidine kinase is located in the cell nucleus. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 11941-11945.